[Translation] An open, multicenter, phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of JRF103 tablets in patients with advanced solid tumors
试验主要目的是评价JRF103片在晚期实体瘤患者的安全性和耐受性,同时评价JRF103片在晚期实体瘤患者的药代动力学特征和JRF103片的初步抗肿瘤疗效,为后续研究提供推荐剂量。
[Translation] The main purpose of the trial is to evaluate the safety and tolerability of JRF103 tablets in patients with advanced solid tumors, as well as to evaluate the pharmacokinetic characteristics of JRF103 tablets in patients with advanced solid tumors and the preliminary anti-tumor efficacy of JRF103 tablets, and to provide recommended doses for subsequent studies.